Cargando…
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf...
Autores principales: | Ahmed, Sabeena, Karim, Mohammad Mahbubul, Ross, Allen G., Hossain, Mohammad Sharif, Clemens, John D., Sumiya, Mariya Kibtiya, Phru, Ching Swe, Rahman, Mustafizur, Zaman, Khalequ, Somani, Jyoti, Yasmin, Rubina, Hasnat, Mohammad Abul, Kabir, Ahmedul, Aziz, Asma Binte, Khan, Wasif Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709596/ https://www.ncbi.nlm.nih.gov/pubmed/33278625 http://dx.doi.org/10.1016/j.ijid.2020.11.191 |
Ejemplares similares
-
A five-day course of ivermectin may reduce the duration of COVID-19 illness
por: Ahmed, Sabeena, et al.
Publicado: (2021) -
A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants
por: Kanchan, Vibhu, et al.
Publicado: (2019) -
Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity
por: Alam, Mohammad Shafiul, et al.
Publicado: (2018) -
Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh
por: Huwe, Tiffany, et al.
Publicado: (2022) -
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2020)